First Product

A patented nanoparticle, Copper-Cysteamine (cu-cy), has the potential to be used in cancer treatments, including radiation therapy, microwave ablation therapy, and sonodynamic therapy. When irradiated, cu-cy nanoparticles fluoresce and then release a reactive oxygen species (singlet oxygen) that can cause extra damage in the tumor.

King Li, MD, MBA, President

Dr. Li is a physician scientist with main research interest in nanotechnology, molecular imaging and integrating imaging with genomic and proteomic analysis for studying systems biology. Dr. Li has a long track record of developing intellectual property and commercializing them as well as setting up and administering large clinical and translational research programs. He is a radiologist and currently Dean and Professor Emeritus of Carle Illinois College of Medicine at University of Illinois Urbana Champaign.  As the Inaugural Dean of the Carle Illinois College of Medicine, Dr. Li is a main driving force in developing the world’s first engineering and technology focused college of medicine.  He is a Fellow of the National Academy of Inventors, American College of Radiology, American Institute for Medical and Biological Engineering, and other professional organizations.